| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Republic of Korea | 5 | |
| #2 | Canada | 3 | |
| #3 | Australia | 2 | |
| #4 | Taiwan | 2 | |
| #5 | EAPO (Eurasian Patent Organization) | 1 | |
| #6 | Hungary | 1 | |
| #7 | Japan | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Analysing materials | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Soucek Laura | 7 |
| #2 | Beaulieu Marie-Eve | 6 |
| #3 | Chigancas Vanesa | 4 |
| #4 | Anido Folgueira Judit | 4 |
| #5 | Sala Hojman Ada | 4 |
| #6 | Soto Simon Atenea | 4 |
| #7 | Huber Ruano Isabel | 4 |
| #8 | Castroviejo Bermejo Marta | 2 |
| #9 | Suarez Joan Seoane | 2 |
| #10 | Balmana Gelpi Judith | 2 |
| Publication | Filing date | Title |
|---|---|---|
| TW202043254A | Methods for the diagnosis of lung cancer | |
| TW202102542A | Combination therapy for the treatment of cancer | |
| AU2016359920A1 | Agents for the treatment of diseases associated with undesired cell proliferation | |
| HUE045615T2 | Methods and compositions for the treatment of cancer | |
| KR20200119344A | Antibody recognizing human leukemia inhibitory factor (lif) and use of anti-lif antibodies in the treatment of diseases associated with unwanted cell proliferation |